NCT05796258Completed
Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
A Multi-institutional Effort With a Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
Source: ClinicalTrials.gov · Last updated 5 Dec 2024
Brief summary (registry, in English)
This multi-center study aims at NTRK fusion testing of all patients with advanced thyroid cancer (any histotype and regardless of stage). The primary objective of this study is to assess the frequency of NTRK fusions in thyroid cancer. The secondary objective of this study is to develop an effective tool (testing) strategy for the detection of NTRK fusions in thyroid tumors, comparing the diagnostic tecniques available (IHC, real-time PCR and NGS).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 16 Mar 2023
- Start date
- 26 Jul 2021
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Regina Elena Cancer Institute
- Diseases
- Thyroid cancer, Childhood cancers
- NCT number
- NCT05796258
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 26 Jul 2021 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with non-advanced thyroid cancer
Other
- Patients with thyroid neoplasms without appropriate material for subsequent immunohistochemical and molecular studies;
Who the study is looking for
- Diagnosis of advanced thyroid cancer (any histotype)
- Informed consent.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Regina Elena National Cancer Institute Coordinator of this site? Confirm its status | Roma | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.